News Search Results
Jun 19, 2026, 05:00 ET Gelatin Market worth $6.43 billion by 2031- Exclusive Report by MarketsandMarkets™
B.V. (Netherlands), Shandong Hengxin Biotech Co., Ltd. (China), Baotou Dongbao Bio-Tech Co., Ltd. (China), FUJIAN FUNINGPU BIOTECHNOLOGY CO., LTD (China), Sichuan Raybo Biotechnology Co., Ltd. (China), Shandong Jiruite Gelatin Co., Ltd (China), and others.Get 10% Free Customization on this Report:
More news about: MarketsandMarkets
Jun 18, 2026, 14:54 ET WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, closed its previously
More news about: WallachBeth Capital LLC
Jun 18, 2026, 13:07 ET KROMATID Names Matthew Hemstreet CEO as Company Advances Toward Market Leadership in Cell & Gene Therapy
and gene therapy.Expanded and enhanced the genomic analysis portfolio to meet the evolving needs of pharmaceutical, biotechnology, and academic research organizations.Developed a genomic intelligence platform leveraging KROMATID's unique access to
More news about: KROMATID
Jun 18, 2026, 12:58 ET Chandigarh University in collaboration with CIPU hosts 3rd Bharat Higher Education Summit 2026
integrate Indian knowledge systems such as Ayurveda, Yoga, Sanskrit and the classical mathematics alongside with cutting edge AI, Quantum Computing and Biotechnology. Our students should be equally fluent in AW and AI, Ancient wisdom and artificial intelligence. That is what it means to restore India's place
More news about: Chandigarh University
Jun 18, 2026, 12:00 ET Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture
Sana Biotechnology,
More news about: Flagship Pioneering
Jun 18, 2026, 11:29 ET Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and BIO 2026
Deck Bio, a biotechnology company advancing multi-pMHC targeted T cell engagers for solid tumors, today announced its participation in the
More news about: Deck Bio, Inc.
Jun 18, 2026, 10:09 ET SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC
on June 17, 2025, representing a 48,650% increase. The Wall Street Journal noted in January 2026 that only 20 of the 261 companies in the Nasdaq Biotechnology Index had a greater market value than Regencell.Alleged Operational Disconnects by the NumbersRegencell's
More news about: SueWallSt.com
Jun 18, 2026, 10:01 ET Feed Enzymes Market 2026-2036: Capital Reallocation, Precision Nutrition Expansion, and Regulatory-Driven Transformation in Enzyme-Based Livestock Nutrition Systems
FMI.Competitive Landscape and Market Share AnalysisThe competitive landscape remains moderately consolidated, with leading biotechnology companies, animal nutrition specialists, and feed additive manufacturers competing through enzyme innovation, fermentation capabilities, species-specific
More news about: Future Market Insights
Jun 18, 2026, 10:01 ET Chronic Inflammatory Demyelinating Polyneuropathy Market Gains Traction During the Forecast Period (2026-2036) with Advancing Clinical Research Activities | DelveInsight
formulations has improved treatment accessibility and patient compliance.Expanding Research and Development Activities: Pharmaceutical and biotechnology companies are significantly investing in research and development to introduce innovative therapies for CIDP. The growing clinical pipeline of therapies
More news about: DelveInsight Business Research, LLP
Jun 18, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
$14 billion. As The Wall Street Journal observed in January 2026, "[f]or context, only 20 of the 261 companies in the Nasdaq Biotechnology Index had a greater market value; the index doesn't include Regencell." At all relevant times, Defendants downplayed the likelihood and severity
More news about: Pomerantz LLP
Jun 18, 2026, 09:00 ET Final Entry Deadline Extended in The 23rd Annual International Business Awards®
awards have also introduced new industry sectors throughout the Company of the Year, Entrepreneur, and Management categories, including Agritech, Biotechnology, Cybersecurity, E-commerce, Education & EdTech, Gaming & Esports, Logistics & Supply Chain, and Venture Capital.The program has
More news about: The Stevie Awards
Jun 18, 2026, 08:00 ET Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
emerging advanced therapy companies through collaborative partnerships and open access development strategies.About Matica Biotechnology, Inc.Matica Biotechnology is a viral vector Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at its purpose-built
More news about: Matica Biotechnology, Inc.
Jun 18, 2026, 08:00 ET Kalohexis Appoints Xuan Hui, B.Med., M.S., Ph.D., as Director of Corporate Strategy
NORTHBROOK, Ill., June 18, 2026 /PRNewswire/ -- Kalohexis, Inc., a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced
More news about: Kalohexis
Jun 18, 2026, 08:00 ET Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
Inc., a biotech at the forefront of cryo-electron microscopy (cryo-EM)–driven drug design, and Zymeworks Inc. (Nasdaq: ZYME), a global biotechnology company, have partnered to visualize structures of antibody-antigen interfaces at high resolution. While cryo-EM is now used routinely to
More news about: Gandeeva Therapeutics Inc.
Jun 18, 2026, 07:07 ET Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
18, 2026 /PRNewswire/ -- The BIO International Convention, held each June in San Diego, is where dealmaking meets discovery. As the global biotechnology sector continues shifting toward precision medicine, advanced therapeutics, and translational diagnostics, the convention floor has become less
More news about: GeneOnline
Jun 18, 2026, 06:55 ET IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in International Commercialization
SHANGHAI, NANJING, and PLEASANTON, Calif., June 18, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel
More news about: IASO Bio
Jun 18, 2026, 06:45 ET TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2026
ANGELES, June 18, 2026 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical stage oncology-focused biotechnology company, today announced preliminary Phase 1 safety and efficacy data of ixotatug vedotin (Ixo-V or TORL-1-23) in combination with bevacizumab in
More news about: TORL Biotherapeutics LLC
Jun 18, 2026, 06:15 ET Epson Robots to Showcase SafeSense Technology, High-Performance, Compact SCARA and 6-Axis Solutions and First Look at Epson Collaborative Robot at Automate 2026
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Jun 17, 2026, 12:02 ET Metabolic Supply Group Launches Metabolic Research Network (MRN), Connecting Med Spas, Longevity Clinics, and Telehealth Providers to Clinical Research Opportunities Nationwide
innovation while helping advance the future of medicine."The Metabolic Research Network will collaborate with pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic institutions, decentralized trial operators, and clinical research sites to
More news about: Metabolic Supply Group
Jun 17, 2026, 11:56 ET Lupin Launches Azilsartan Medoxomil Tablets in the United States
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
Jun 17, 2026, 10:45 ET The 16th Annual Globee® Awards for Business Invite Healthcare, Medical Technology, and Pharmaceutical Organizations Worldwide to Nominate Their Achievements
participate, including hospitals, healthcare systems, clinics, medical technology companies, diagnostics providers, pharmaceutical organizations, biotechnology companies, healthcare software providers, research-driven organizations, and related institutions worldwide.Nominations are welcomed for
More news about: Globee Awards
Jun 17, 2026, 10:41 ET WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, priced a Public
More news about: WallachBeth Capital LLC
Jun 17, 2026, 10:15 ET Transplant Diagnostics Market worth $8.14 billion by 2031 | MarketsandMarkets™
modernization and automation of diagnostic laboratories, the increasing number of research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories, and the growing consolidation of diagnostic laboratories in developed countries. Additionally,
More news about: MarketsandMarkets
Jun 17, 2026, 10:01 ET GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research
Landscape Moves Toward Outcomes, Capacity, and AccessThe GLP-1 Receptor Agonists Market includes major pharmaceutical and biotechnology companies such as Novo Nordisk, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Zealand Pharma, Amgen, and Innovent Biologics.Competition
More news about: Strategic Market Research LLP
Jun 17, 2026, 10:00 ET LG AI Research Announces Collaboration with D&D Pharmatech to accelerate next-generation oral peptide drug discovery
RecommendationsLG AI Research has been steadily developing innovative "Biology AI" models to treat various diseases through the convergence of AI and biotechnology.A prime example is "Cancer Agentic AI," a personalized precision medicine AI platform being developed in collaboration with Professor
More news about: LG